يعرض 81 - 90 نتائج من 233 نتيجة بحث عن '"Yukari Tsubata"', وقت الاستعلام: 0.82s تنقيح النتائج
  1. 81
    Picropodophyllin inhibits the growth of pemetrexed-resistant malignant pleural mesothelioma via microtubule inhibition and IGF-1R-, caspase-independent pathways

    المؤلفون: Rong Sun, Ryosuke Tanino, Xuexia Tong, Eshat Fahmida Haque, Yoshihiro Amano, Takeshi Isobe, Yukari Tsubata

    المصدر: Transl Lung Cancer Res

    مصطلحات موضوعية: Oncology, Original Article

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e83d03c36b6c4b9772a829fd18f32b1cTest
    https://doi.org/10.21037/tlcr-21-765Test


    أضف إلى المفضلة
  2. 82
    A Rare Case of Acute Fibrinous and Organizing Pneumonia Associated with Systemic Lupus Erythematosus and Autoimmune-associated Hemophagocytic Syndrome: The Involvement of CD163-positive Macrophages

    المؤلفون: Yasuko Wada, Koji Kishimoto, Takeshi Matsumura, Yohko Murakawa, Masahiro Kondo, Mayuko Moriyama, Emiko Nishikawa, Mamiko Nagase, Yukari Tsubata, Yoshiko Sumita, Noriyoshi Ishikawa, Mariko Taira

    المصدر: Internal Medicine. 61:559-565

    مصطلحات موضوعية: Pathology, medicine.medical_specialty, Antigens, Differentiation, Myelomonocytic, Receptors, Cell Surface, Lymphohistiocytosis, Hemophagocytic, Fibrin, Antigens, CD, Internal Medicine, Humans, Lupus Erythematosus, Systemic, Medicine, Pathological, Lung, biology, business.industry, CD68, Macrophages, Pneumonia, General Medicine, respiratory system, medicine.disease, respiratory tract diseases, medicine.anatomical_structure, biology.protein, Organizing pneumonia, Antibody, business, CD163

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::868f1696482a7e3492612156ed091ff0Test
    https://doi.org/10.2169/internalmedicine.7184-21Test


    أضف إلى المفضلة
  3. 83
    Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial

    المؤلفون: Kunihiko Kobayashi, Hiromi Nagashima, Gyo Asai, Yosuke Kawashima, Shunichi Sugawara, Kana Watanabe, Naoki Furuya, Masahiro Seike, Ichiro Nakachi, Koichi Azuma, Satoshi Watanabe, Morihito Okada, Ou Yamaguchi, Yoshio Tsunezuka, Yukari Tsubata, Haruhiro Saito, Makoto Maemondo, Koichi Hagiwara, Masaki Miyazaki, Shunichiro Iwasawa, Kozo Yoshimori, Futoshi Kurimoto, Yuka Fujita, Toshihiro Nukiwa, Satoshi Morita, Tatsuro Fukuhara

    المصدر: The Lancet Respiratory Medicine. 10:72-82

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Lung Neoplasms, Bevacizumab, Combination therapy, Population, Disease-Free Survival, Erlotinib Hydrochloride, Japan, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Lung cancer, education, education.field_of_study, business.industry, Hazard ratio, medicine.disease, Survival Analysis, ErbB Receptors, Clinical trial, Quality of Life, Erlotinib, business, Progressive disease, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e06dbd6beba5b3e41be5f0ed8a144eb5Test
    https://doi.org/10.1016/s2213-2600Test(21)00166-1


    أضف إلى المفضلة
  4. 84
    Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B)

    المؤلفون: Kiyotaka Miura, Ryota Saito, Kensuke Nakazawa, Takeshi Isobe, Ryoichi Honda, Yuki Akazawa, Nobuhiro Kanaji, Susumu Takeuchi, Yukari Tsubata, Kana Watanabe, Satoshi Morita, Kunihiko Kobayashi, Taku Nakagawa, Atsushi Nakamura, Naoki Furuya, Daisuke Jingu, Eiki Ichihara, Atsuto Mouri, Satoshi Ohizumi, Makoto Maemondo, Mami Morita, Hiroshige Yoshioka

    المصدر: International Journal of Clinical Oncology

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Afatinib, Phases of clinical research, EGFR T790M, T790M, Gefitinib, Internal medicine, medicine, Clinical endpoint, Osimertinib, Lung cancer, Poor performance status, business.industry, Hematology, General Medicine, medicine.disease, Phase II, respiratory tract diseases, Surgery, Original Article, Erlotinib, business, Non-small-cell lung cancer, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83096e34e31b1e0f189ad2972dcda7c1Test
    http://europepmc.org/articles/PMC8732858Test


    أضف إلى المفضلة
  5. 85
    Comparative Analysis of the Attitudes toward Palliative Care between Medical Oncologists and Pulmonologists

    المؤلفون: Takamasa Hotta, Shunichi Hamaguchi, Megumi Hamaguchi, Tamio Okimoto, Mika Nakao, Yukari Tsubata, Takeshi Isobe

    المصدر: Internal Medicine

    مصطلحات موضوعية: medical oncologist, medicine.medical_specialty, Palliative care, Referral, Attitude of Health Personnel, Specialty, 030204 cardiovascular system & hematology, chemotherapy, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Internal Medicine, Humans, Outpatient clinic, Medicine, Medical history, pulmonologist, Pulmonologists, Retrospective Studies, Oncologists, palliative care, business.industry, Pulmonologist, General Medicine, lung cancer, Family medicine, Original Article, 030211 gastroenterology & hepatology, business, End-of-life care

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fa84179d82cbe9f1d9a48f847274d01Test
    http://ir.lib.shimane-u.ac.jp/54699Test


    أضف إلى المفضلة
  6. 86
    ERCC1 Is a Predictive Biomarker for Non-small Cell Lung Cancer But Is Antibody-dependent

    المؤلفون: Megumi Hamaguchi, Takamasa Hotta, Shunichi Hamaguchi, Tamio Okimoto, Mika Nakao, Ryosuke Tanino, Asuka Araki, Yukari Tsubata, Takeshi Isobe

    المصدر: Anticancer Research. 41:2653-2660

    مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Carcinoma, Non-Small-Cell Lung, Internal medicine, Biomarkers, Tumor, medicine, Humans, In patient, Lung cancer, Aged, Platinum, Predictive biomarker, Aged, 80 and over, Chemotherapy, biology, business.industry, General Medicine, Middle Aged, Endonucleases, medicine.disease, Antibodies, Anti-Idiotypic, DNA-Binding Proteins, Gene Expression Regulation, Neoplastic, biology.protein, Immunohistochemistry, Female, Non small cell, ERCC1, Antibody, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32219aaa78f810097a6ae27ad8573f28Test
    https://doi.org/10.21873/anticanres.15046Test


    أضف إلى المفضلة
  7. 87
    Osimertinib versus osimertinib plus chemotherapy for non–small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial

    المؤلفون: Shunichi Sugawara, Junji Kishimoto, Hajime Asahina, Kenji Sugio, Yukari Tsubata, Yoshihiro Miyata, Kana Watanabe, Kosuke Hamai, Taishi Harada, Takahiro Uchida, Isamu Okamoto, Satoshi Oizumi, Kentaro Tanaka, Kunihiko Kobayashi

    المصدر: European Journal of Cancer. 149:14-22

    مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Time Factors, Combination therapy, Pemetrexed, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, T790M, 0302 clinical medicine, Japan, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, Osimertinib, Protein Kinase Inhibitors, Aged, Aged, 80 and over, Acrylamides, Aniline Compounds, business.industry, Standard treatment, Middle Aged, Progression-Free Survival, ErbB Receptors, 030104 developmental biology, chemistry, Tolerability, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Mutation, Female, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e08253a3dfa77690711faf8a43d04014Test
    https://doi.org/10.1016/j.ejca.2021.02.019Test


    أضف إلى المفضلة
  8. 88
    Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data

    المؤلفون: Yukari Tsubata, Keita Kawakado, Kosuke Hamai, Naoki Furuya, Toshihide Yokoyama, Ryota Saito, Atsushi Nakamura, Takeshi Masuda, Megumi Hamaguchi, Shoichi Kuyama, Ryoichi Honda, Tadashi Senoo, Masamoto Nakanishi, Takamasa Hotta, Masahiro Yamasaki, Nobuhisa Ishikawa, Kazunori Fujitaka, Tetsuya Kubota, Kunihiko Kobayashi, Takeshi Isobe

    المصدر: International journal of clinical oncology.

    مصطلحات موضوعية: Oncology, Surgery, Hematology, General Medicine

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7256b4ce2587c3d1add2f8786bb062adTest
    https://pubmed.ncbi.nlm.nih.gov/36357710Test


    أضف إلى المفضلة
  9. 89
    Abstract 2797: Multicenter pharmacokinetic study of pembrolizumab for non-small cell lung cancer in older adults aged over 75 years

    المؤلفون: Yoshiro Nakahara, Kageaki Watanabe, Yukio Hosomi, Yuta Yamanaka, Takayasu Kurata, Hidehito Horinouchi, Yuichiro Ohe, Tetsuhiko Asao, Sho Saeki, Yukari Tsubata, Yu Fujita, Jun Sakakibara Konishi, Hidenori Mizugaki, Mayu Ohuchi, Shigehiro Yagishita, Akinobu Hamada

    المصدر: Cancer Research. 83:2797-2797

    مصطلحات موضوعية: Cancer Research, Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a2eb280122bc63fee535707d41dd7e51Test
    https://doi.org/10.1158/1538-7445.am2023-2797Test


    أضف إلى المفضلة
  10. 90
    Novel prospective umbrella‐type lung cancer registry study for clarifying clinical practice patterns: CS‐Lung‐003 study protocol

    المؤلفون: Yutaka Ueda, Masaaki Inoue, Nobuhisa Ishikawa, Hideto Obata, Masahiro Kodani, Shoichi Kuyama, Kazuya Nishii, Takuo Shibayama, Katsuyuki Hotta, Tetsuya Kubota, Tomoya Ishii, Kazunori Fujitaka, Hirohisa Ichikawa, Nobukazu Fujimoto, Masahiro Yamasaki, Yukari Tsubata, Daizo Kishino, Yoshikazu Awaya, Toshiyuki Kozuki, Tomonori Moritaka, Keisuke Sugimoto, Kenichi Gemba, Katsuyuki Kiura

    المصدر: Thoracic Cancer, Vol 12, Iss 5, Pp 725-731 (2021)
    Thoracic Cancer

    مصطلحات موضوعية: Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Lung Neoplasms, Disease, lcsh:RC254-282, Database, Study Protocol, 03 medical and health sciences, 0302 clinical medicine, medicine, Clinical endpoint, Humans, Prospective Studies, Registries, Intensive care medicine, Lung cancer, Protocol (science), treatment, business.industry, Cancer, General Medicine, Patient registration, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cancer registry, real world data, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, surveillance, Female, Observational study, observational study, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3affbf5c7d047817775db35dd5a08ac7Test
    https://doaj.org/article/39cc5a45f0b247419b90dcc755431024Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث